Skip to content

The application of micuronium chloride in surgery for urinary tract stones

The application of micuronium chloride in surgery for urinary tract stones: a single center, prospective, double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081644
Enrollment
Unknown
Registered
2024-03-07
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary tract stones

Interventions

micuronium chloride group:Propofol 2.5mg/kg+sufentanil 0.25ug/kg+micuronium chloride 0.2mg/kg iv
physiological saline group:Propofol 2.5mg/kg+sufentanil 0.25ug/kg+Equal amount of physiological saline

Sponsors

Weihai Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Age range from 18 to 75 years old, regardless of gender; ? During the screening period, if imaging examination indicates urinary tract stones (bladder stones, ureteral stones, or kidney stones) and intends to treat the stones through endoscopy; ? Voluntarily participate in this clinical trial and sign the subject's informed consent form

Exclusion criteria

Exclusion criteria: ? Planned ureteroscopic lithotripsy with a maximum diameter of stones>3cm; Or ureteral stenosis, with the lesion located above the stenosis; ? Those who plan to undergo percutaneous nephrolithotripsy, but the distance between the skin and kidneys exceeds 20cm or it is inconvenient to establish a channel; ? Suspected or diagnosed with prostate cancer or urinary system tumors; ? There is a tendency for bleeding or coagulation dysfunction (prothrombin time = 1.5 times the upper limit of normal values) and a decrease in platelets (PLT) (<80 × 109/L), patients with hemorrhagic blood system diseases such as aplastic anemia; ? Those with active, systemic and infectious diseases; ? Individuals who have participated in other intervention clinical trials within the month prior to this trial ? are allergic to the study medication ? Patients with mental illness cannot cooperate with follow-up Researchers believe that participants who are not suitable for this clinical trial

Design outcomes

Primary

MeasureTime frame
Patient's systolic blood pressure, diastolic blood pressure, mean blood pressure, herat rate;

Secondary

MeasureTime frame
Patient's placement of laryngeal mask (no resistance, mild resistance, significant resistance, unable to be inserted);Injury situation of laryngeal mask insertion(Patient's sore throat score; Is there blood on the surface of the laryngeal mask when removing it);Total demand for propofol and remifentanil during patient anesthesia maintenance phase;The time required for the patient to recover from surgery;Patient experiences nausea, vomitingafter resuscitation;Hospitalization time and hospitalization expenses;Surgical physician satisfaction;Patient pain after resuscitation(NRS scoring system);Patient pain after resuscitation(NRS scoring system);

Countries

China

Contacts

Public ContactChi lei

Weihai Municipal Hospital

595388022@qq.com+86 152 6313 9896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026